Cenduit, a global provider of patient randomization and clinical supplies management services, has announced the expansion of its Durham, N.C., headquarters and its office in Basel, Switzerland. The expansion adds substantial space to the company’s headquarters and triples the size of its office in Basel.

“The increase in offices and infrastructure is required to support our global investment in capacity,” said Jogin Desai, CEO. “Our aim is to provide the best possible support to sites and sponsors and to do this through continued investment in our customer-facing groups.”

News of the expansion comes in tandem with Cenduit’s recent appointment of Chris Dailey as global head of technology. Dailey joins Cenduit with more than 15 years of interactive, software and telecommunications experience. In his role as global head of technology, Dailey will lead technology and service initiatives aimed at providing additional system functionality as well as improving the user experience for those interfacing with Cenduit Interactive Response Technology (IRT) to conduct clinical trials at sites across the globe.

“The expansion and the acquisition of senior leadership like Chris give us the bandwidth to execute our plans to implement new technologies and augment the breadth of services that we provide to sponsors,” said Desai. “Our top priority is enabling investigator sites to achieve overall compliance through seamless management of patient enrollment and treatment throughout the clinical trial.”